188 related articles for article (PubMed ID: 25333256)
1. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells.
Sutton SK; Koach J; Tan O; Liu B; Carter DR; Wilmott JS; Yosufi B; Haydu LE; Mann GJ; Thompson JF; Long GV; Liu T; McArthur G; Zhang XD; Scolyer RA; Cheung BB; Marshall GM
Oncotarget; 2014 Oct; 5(20):10127-39. PubMed ID: 25333256
[TBL] [Abstract][Full Text] [Related]
2. A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner.
Sutton SK; Carter DR; Kim P; Tan O; Arndt GM; Zhang XD; Baell J; Noll BD; Wang S; Kumar N; McArthur GA; Cheung BB; Marshall GM
Oncotarget; 2016 Aug; 7(32):52166-52178. PubMed ID: 27447557
[TBL] [Abstract][Full Text] [Related]
3. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.
Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168
[TBL] [Abstract][Full Text] [Related]
5. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion.
Li L; Dong L; Qu X; Jin S; Lv X; Tan G
Int J Oncol; 2016 Apr; 48(4):1639-49. PubMed ID: 26892350
[TBL] [Abstract][Full Text] [Related]
6. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract][Full Text] [Related]
7. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization.
Bell JL; Malyukova A; Kavallaris M; Marshall GM; Cheung BB
Cell Cycle; 2013 Mar; 12(6):889-98. PubMed ID: 23422002
[TBL] [Abstract][Full Text] [Related]
8. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.
Kim PY; Tan O; Liu B; Trahair T; Liu T; Haber M; Norris MD; Marshall GM; Cheung BB
Cancer Lett; 2016 May; 374(2):315-23. PubMed ID: 26902425
[TBL] [Abstract][Full Text] [Related]
9. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.
Qi L; Lu Z; Sun YH; Song HT; Xu WK
Int J Mol Med; 2016 Dec; 38(6):1734-1742. PubMed ID: 27748839
[TBL] [Abstract][Full Text] [Related]
10. The plasma membrane Ca
Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
[TBL] [Abstract][Full Text] [Related]
11. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A activates TRIM16 for its anti-cancer activity in melanoma.
Nagy Z; Cheung BB; Tsang W; Tan O; Herath M; Ciampa OC; Shadma F; Carter DR; Marshall GM
Sci Rep; 2020 Nov; 10(1):19724. PubMed ID: 33184347
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
[TBL] [Abstract][Full Text] [Related]
14. Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.
Beck D; Niessner H; Smalley KS; Flaherty K; Paraiso KH; Busch C; Sinnberg T; Vasseur S; Iovanna JL; Drießen S; Stork B; Wesselborg S; Schaller M; Biedermann T; Bauer J; Lasithiotakis K; Weide B; Eberle J; Schittek B; Schadendorf D; Garbe C; Kulms D; Meier F
Sci Signal; 2013 Jan; 6(260):ra7. PubMed ID: 23362240
[TBL] [Abstract][Full Text] [Related]
15. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
16. TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells.
Kim PY; Rahmanto AS; Tan O; Norris MD; Haber M; Marshall GM; Cheung BB
Apoptosis; 2013 May; 18(5):639-51. PubMed ID: 23404198
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
18. BRAF
Lunavat TR; Cheng L; Einarsdottir BO; Olofsson Bagge R; Veppil Muralidharan S; Sharples RA; Lässer C; Gho YS; Hill AF; Nilsson JA; Lötvall J
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5930-E5939. PubMed ID: 28684402
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin-5A downregulation is associated with enhanced migration and invasion of BRAF-positive melanoma cells under vemurafenib treatment in melanomas with heterogeneous BRAF status.
Komina AV; Palkina NV; Aksenenko MB; Lavrentev SN; Moshev AV; Savchenko AA; Averchuk AS; Rybnikov YA; Ruksha TG
Melanoma Res; 2019 Oct; 29(5):544-548. PubMed ID: 31116162
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
Wang N; Zhang T
Oncol Res; 2018 Aug; 26(7):1005-1014. PubMed ID: 29295721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
